We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$820M
AUM Growth
+$14.5M
Cap. Flow
-$58.3M
Cap. Flow %
-7.11%
Top 10 Hldgs %
15.04%
Holding
537
New
56
Increased
73
Reduced
203
Closed
92

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$6.12M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$5.37M
3
ST icon
Sensata Technologies
ST
+$5.01M
4
DRIO icon
DarioHealth
DRIO
+$3.05M
5
TWTR
Twitter, Inc.
TWTR
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 24.55%
2 Healthcare 17.09%
3 Industrials 12.67%
4 Materials 10.49%
5 Consumer Discretionary 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PS
526
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
-73,916
Closed -$1.55M
SMTX
527
DELISTED
SMTC Corporation
SMTX
-174,661
Closed -$866K
OXFD
528
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-111,757
Closed -$1.95M
PE
529
DELISTED
PARSLEY ENERGY INC
PE
-1,500
Closed -$21K
PFSW
530
DELISTED
PFSweb, Inc.
PFSW
-185,571
Closed -$1.25M
STMP
531
DELISTED
Stamps.com, Inc.
STMP
-7,667
Closed -$1.5M
RNWK
532
DELISTED
RealNetworks Inc
RNWK
-184,507
Closed -$288K

Similar funds

Essex Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Essex Investment Management held 537 positions worth $820M, up 1.8% from $806M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Essex Investment Management withdrew a net $58.3M in Q1 2021, closing 92 positions and reducing 203 holdings. Its most notable exit was VeriSign, an estimated $5.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in CRISPR Therapeutics worth $4.33M.

  • Essex Investment Management's largest Q1 2021 buy was CRISPR Therapeutics: 35,540 shares worth $4.33M.
  • Essex Investment Management added most to AT&T in Q1 2021, an estimated $6.12M increase.
  • Essex Investment Management's biggest Q1 2021 reduction was Teladoc Health, cutting an estimated $8.61M.
  • Essex Investment Management fully exited VeriSign in Q1 2021, selling an estimated $5.32M.
  • Essex Investment Management's ten largest holdings make up 15% of its $820M portfolio in Q1 2021.
  • Essex Investment Management opened 56 new positions and closed 92 in Q1 2021.
  • Essex Investment Management's portfolio value rose 1.8% quarter-over-quarter to $820M.

Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.